People with glaucoma, a disease that can lead to blindness, might some day be better able to treat their illness, thanks to an agreement between UW-Madison and a North Carolina biopharmaceutical company.
People with glaucoma, a disease that can lead to blindness, might some day be better able to treat their illness, thanks to an agreement between UW-Madison and a North Carolina biopharmaceutical company.